Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer.
Fordham BA, Kerr C, de Freitas HM, Lloyd AJ, Johnston K, Pelletier CL, Tremblay G, Forsythe A, McIver B, Cohen EE.
Fordham BA, et al. Among authors: johnston k.
Patient Prefer Adherence. 2015 Nov 3;9:1561-72. doi: 10.2147/PPA.S90425. eCollection 2015.
Patient Prefer Adherence. 2015.
PMID: 26604709
Free PMC article.